Volume 9, Number 6—June 2003
Clinical Implications of Varying Degrees of Vancomycin Susceptilibity in Methicillin-Resistant Staphylococcus aureus Bacteremia1
|Outcome||Case-patients n=61 (%)||Controls n=87 (%)||p value (unadjusted)||p value (adjusted for severity of illness)|
|Discharged to home||13 (22)||22 (25)|
|Discharged to an institution||32 (52)||42 (48)||0.83||0.67|
|Died during hospitalization||16 (26)||23 (26)|
1Presented in part at the 41st Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, Illinois, December 2001.